A single amino acid deletion in the matrix protein of porcine reproductive and respiratory syndrome virus confers resistance to a polyclonal swine antibody with broadly neutralizing activity

Journal of Virology

Volumn 89, Issue 12, 2015, Pages 6515-6520

  Trible, Benjamin R ^a   Popescu, Luca N ^a   Monday, Nicholas ^a   Calvert, Jay G ^b   Rowland, Raymond R R ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MATRIX PROTEIN; POLYCLONAL ANTIBODY; TYROSINE; M PROTEIN, PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

AMINO ACID DELETION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; VIRUS ENTRY; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; DNA SEQUENCE; GENE DELETION; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; PIG;

PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; MOLECULAR SEQUENCE DATA; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; SWINE; TYROSINE; VIRAL MATRIX PROTEINS;

EID: 84929598311     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03287-14     Document Type: Article

References (42)

1. Snijder EJ, Spaan WJM. 2007. Arteriviruses, p 1337-1355. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Huang YW, Meng XJ. 2010. Novel strategies and approaches to develop the next generation of vaccines against porcine reproductive and respiratory syndrome virus (PRRSV). Virus Res 154:141-149. http://dx.doi.org/10.1016/j.virusres.2010.07.020.
3. Darwich L, Díaz I, Mateu E. 2010. Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology. Virus Res 154:123-132. http://dx.doi.org/10.1016/j.virusres.2010.07.017.
4. Fang Y, Schneider P, Zhang WP, Faaberg KS, Nelson EA, Rowland RRR. 2007. Diversity and evolution of a newly emerged North American type 1 porcine arterivirus: analysis of isolates collected between 1999 and 2004. Arch Virol 152:1009-1017. http://dx.doi.org/10.1007/s00705-007-0936-y.
5. Rowland RRR, Steffen M, Ackerman T, Benfield DA. 1999. The evolution of porcine reproductive and respiratory syndrome virus: quasispecies and emergence of a virus subpopulation during infection of pigs with VR-2332. Virology 259:262-266. http://dx.doi.org/10.1006/viro.1999.9789.
6. Ansari IH, Kwon B, Osorio FA, Pattnaik AK. 2006. Influence of Nlinked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol 80:3994-4004. http://dx.doi.org/10.1128/JVI.80.8.3994-4004.2006.
7. Snijder EJ, Dobbe JC, Spaan WJM. 2003. Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. J Virol 77: 97-104. http://dx.doi.org/10.1128/JVI.77.1.97-104.2003.
8. Wissink EHJ, Kroese MV, van Wijk HAR, Rijsewijk FAM, Meulenberg JJM, Rottier PJM. 2005. Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus. J Virol 79:12495-12506. http://dx.doi.org/10.1128/JVI.79.19.12495-12506.2005.
9. Wu W-H, Fang Y, Rowland RRR, Lawson SR, Christopher-Hennings J, Yoon K-J, Nelson EA. 2005. The 2b protein as a minor structural component of PRRSV. Virus Res 114:177-181. http://dx.doi.org/10.1016/j.virusres.2005.06.014.
10. Firth AE, Zevenhoven-Dobbe JC, Wills NM, Go YY, Balasuriya UBR, Atkins JF, Snijder EJ, Posthuma CC. 2011. Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production. J Gen Virol 92:1097-1106. http://dx.doi.org/10.1099/vir.0.029264-0.
11. Johnson CR, Griggs TF, Gnanandarajah J, Murtaugh MP. 2011. Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J Gen Virol 92:1107-1116. http://dx.doi.org/10.1099/vir.0.030213-0.
12. Meulenberg JJ, van Nieuwstadt AP, van Essen-Zandbergen A, Langeveld JP. 1997. Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus. J Virol 71:6061-6067.
13. Vanhee M, Costers S, Van Breedam W, Geldhof MF, Van Doorsselaere J, Nauwynck HJ. 2010. A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains. Viral Immunol 23:403-413. http://dx.doi.org/10.1089/vim.2010.0025.
14. Costers S, Lefebvre DJ, Van Doorsselaere J, Vanhee M, Delputte PL, Nauwynck HJ. 2010. GP4 of porcine reproductive and respiratory syndrome virus contains a neutralizing epitope that is susceptible to immunoselection in vitro. Arch Virol 155:371-378. http://dx.doi.org/10.1007/s00705-009-0582-7.
15. Vanhee M, Van Breedam W, Costers S, Geldhof M, Noppe Y, Nauwynck H. 2011. Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies. Vaccine 29:4794-4804. http://dx.doi.org/10.1016/j.vaccine.2011.04.071.
16. Ostrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, Lopez OJ. 2002. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol 76:4241-4250. http://dx.doi.org/10.1128/JVI.76.9.4241-4250.2002.
17. Plagemann PGW, Rowland RRR, Faaberg KS. 2002. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol 147:2327-2347. http://dx.doi.org/10.1007/s00705-002-0887-2.
18. Li K, Chen Z, Plagemann P. 1998. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Virology 242:239-245. http://dx.doi.org/10.1006/viro.1997.9014.
19. Kim W-I, Yoon K-J. 2008. Molecular assessment of the role of envelopeassociated structural proteins in cross neutralization among different PRRS viruses. Virus Genes 37:380-391. http://dx.doi.org/10.1007/s11262-008-0278-1.
20. Kappes MA, Miller CL, Faaberg KS. 2013. Highly divergent strains of porcine reproductive and respiratory syndrome virus incorporate multiple isoforms of nonstructural protein 2 into virions. J Virol 87:13456-13465. http://dx.doi.org/10.1128/JVI.02435-13.
21. Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker L-G, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC. 2009. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J Virol 83:7337-7348. http://dx.doi.org/10.1128/JVI.00110-09.
22. Doria-Rose NA, Klein RM, Manion MM, O'Dell S, Phogat A, Chakrabarti B, Hallahan CW, Migueles SA, Wrammert J, Ahmed R, Nason M, Wyatt RT, Mascola JR, Connors M. 2009. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J Virol 83:188-199. http://dx.doi.org/10.1128/JVI.01583-08.
23. Euler Z, van Gils MJ, Bunnik EM, Phung P, Schweighardt B, Wrin T, Schuitemaker H. 2010. Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. J Infect Dis 201: 1045-1053. http://dx.doi.org/10.1086/651144.
24. Pejchal R, Wilson IA. 2010. Structure-based vaccine design in HIV: blind men and the elephant? Curr Pharm Des 16:3744-3753. http://dx.doi.org/10.2174/138161210794079173.
25. Boddicker N, Waide EH, Rowland RRR, Lunney JK, Garrick DJ, Reecy JM, Dekkers JCM. 2012. Evidence for a major QTL associated with host response to porcine reproductive and respiratory syndrome virus challenge. J Anim Sci 90:1733-1746. http://dx.doi.org/10.2527/jas.2011-4464.
26. Boddicker NJ, Garrick DJ, Rowland RRR, Lunney JK, Reecy JM, Dekkers JCM. 2014. Validation and further characterization of a major quantitative trait locus associated with host response to experimental infection with porcine reproductive and respiratory syndrome virus. Anim Genet 45:48-58. http://dx.doi.org/10.1111/age.12079.
27. Boddicker NJ, Bjorkquist A, Rowland RRR, Lunney JK, Reecy JM, Dekkers JCM. 2014. Genome-wide association and genomic prediction for host response to porcine reproductive and respiratory syndrome virus infection. Genet Sel Evol 46:18. http://dx.doi.org/10.1186/1297-9686-46-18.
28. Lunney JK, Steibel JP, Reecy JM, Fritz E, Rothschild MF, Kerrigan M, Trible B, Rowland RR. 2011. Probing genetic control of swine responses to PRRSV infection: current progress of the PRRS host genetics consortium. BMC Proc 5(Suppl 4):S30. http://dx.doi.org/10.1186/1753-6561-5-S4-S30.
29. Meng XJ, Paul PS, Halbur PG, Lum MA. 1995. Phylogenetic analyses of the putativeM(ORF 6) and N (ORF 7) genes of porcine reproductive and respiratory syndrome virus (PRRSV): implication for the existence of two genotypes of PRRSV in the USA and Europe. Arch Virol 140:745-755. http://dx.doi.org/10.1007/BF01309962.
30. Osorio FA, Galeota JA, Nelson E, Brodersen B, Doster A, Wills R, Zuckermann F, Laegreid WW. 2002. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology 302:9-20. http://dx.doi.org/10.1006/viro.2002.1612.
31. Finney DJ. 1964. The Spearman-Karber method, p 524-530. In Finney DJ (ed), Statistical methods in biological assay, 2nd ed. Charles Griffin, London, United Kingdom.
32. Lee C, Calvert JG, Welch S-KW, Yoo D. 2005. A DNA-launched reverse genetics system for porcine reproductive and respiratory syndrome virus reveals that homodimerization of the nucleocapsid protein is essential for virus infectivity. Virology 331:47-62. http://dx.doi.org/10.1016/j.virol.2004.10.026.
33. Mardassi H, Massie B, Dea S. 1996. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology 221:98-112. http://dx.doi.org/10.1006/viro.1996.0356.
34. Dokland T. 2010. The structural biology of PRRSV. Virus Res 154:86-97. http://dx.doi.org/10.1016/j.virusres.2010.07.029.
35. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
36. Felsenstein J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791. http://dx.doi.org/10.2307/2408678.
37. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120. http://dx.doi.org/10.1007/BF01731581.
38. Reed JL, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
39. Corti D, Lanzavecchia A. 2013. Broadly neutralizing antiviral antibodies. Annu Rev Immunol 31:705-742. http://dx.doi.org/10.1146/annurev-immunol-032712-095916.
40. Van Breedam W, Delputte PL, Van Gorp H, Misinzo G, Vanderheijden N, Duan X, Nauwynck HJ. 2010. Porcine reproductive and respiratory syndrome virus entry into the porcine macrophage. J Gen Virol 91:1659-1667. http://dx.doi.org/10.1099/vir.0.020503-0.
41. Prather RS, Rowland RRR, Ewen C, Trible B, Kerrigan M, Bawa B, Teson JM, Mao J, Lee K, Samuel MS, Whitworth KM, Murphy CN, Egen T, Green JA. 2013. An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus. J Virol 87:9538-9546. http://dx.doi.org/10.1128/JVI.00177-13.
42. Trible BR, Kerrigan M, Crossland N, Potter M, Faaberg K, Hesse R, Rowland RRR. 2011. Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease. Clin Vaccine Immunol 18:749-757. http://dx.doi.org/10.1128/CVI.00418-10.